Literature DB >> 2852388

Establishment and characterization of a cell line from a human cholangiocellular carcinoma.

Y Kusaka1, T Tokiwa, J Sato.   

Abstract

A cell line, HuH-28, was established in vitro from a patient with cholangiocellular carcinoma (CCC). This cell line has grown slowly, revealing a doubling time of approximately 80 h, and the serial passages were carried out 20 times within 10 months. Light microscopy revealed spindle and polygonal morphology of the cells. Chromosome number of the cells were distributed near the hypotriploid region at passages 3 and 14. HuH-28 cells were not transplantable into nude mice, but secreted some tumor markers including alkaline phosphatase (ALP), gamma glutamyltranspeptidase (GGT), beta 2-microglobulin (BMG), ferritin, elastase-1, and tissue polypeptide antigen (TPA). This HuH-28 cell line will represent a good model for the investigation of carcinogenesis, histogenes, and diagnosis of CCC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852388     DOI: 10.1007/bf01851205

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  21 in total

1.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

2.  Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.

Authors:  Domenico Alvaro; Barbara Barbaro; Antonio Franchitto; Paolo Onori; Shannon S Glaser; Gianfranco Alpini; Heather Francis; Luca Marucci; Paola Sterpetti; Stefano Ginanni-Corradini; Andrea Onetti Muda; David E Dostal; Adriano De Santis; Adolfo F Attili; Antonio Benedetti; Eugenio Gaudio
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

3.  Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth.

Authors:  Chad Hall; Laurent Ehrlich; Julie Venter; April O'Brien; Tori White; Tianhao Zhou; Tien Dang; Fanyin Meng; Pietro Invernizzi; Francesca Bernuzzi; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Cancer Lett       Date:  2016-11-26       Impact factor: 8.679

4.  Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.

Authors:  Fanyin Meng; Sharon DeMorrow; Julie Venter; Gabriel Frampton; Yuyan Han; Heather Francis; Holly Standeford; Shanika Avila; Kelly McDaniel; Matthew McMillin; Syeda Afroze; Micheleine Guerrier; Morgan Quezada; Debolina Ray; Lindsey Kennedy; Laura Hargrove; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-03-06       Impact factor: 4.052

5.  Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡).

Authors:  Heping Yang; Ting Liu; Jiaohong Wang; Tony W H Li; Wei Fan; Hui Peng; Anuradha Krishnan; Gregory J Gores; Jose M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2016-04-28       Impact factor: 17.425

6.  Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.

Authors:  Paolo Onori; Sharon DeMorrow; Eugenio Gaudio; Antonio Franchitto; Romina Mancinelli; Julie Venter; Shelley Kopriva; Yoshiyuki Ueno; Domenico Alvaro; Jennifer Savage; Gianfranco Alpini; Heather Francis
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

7.  Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor.

Authors:  A Mancino; M G Mancino; S S Glaser; G Alpini; A Bolognese; L Izzo; H Francis; P Onori; A Franchitto; S Ginanni-Corradini; E Gaudio; D Alvaro
Journal:  Dig Liver Dis       Date:  2008-04-18       Impact factor: 4.088

8.  ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 Expression.

Authors:  Yurie Soejima; Miho Takeuchi; Nao Miyamoto; Motoji Sawabe; Toshio Fukusato
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

9.  Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.

Authors:  Gábor Lendvai; Tímea Szekerczés; Ildikó Illyés; Milán Csengeri; Krisztina Schlachter; Erzsébet Szabó; Gábor Lotz; András Kiss; Katalin Borka; Zsuzsa Schaff
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

Review 10.  The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.

Authors:  Abigail Zabron; Robert J Edwards; Shahid A Khan
Journal:  Dis Model Mech       Date:  2013-03       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.